Status:
COMPLETED
Mindfulness- Based Intervention for Fibromyalgia Patients
Lead Sponsor:
Bar-Ilan University, Israel
Collaborating Sponsors:
Sheba Medical Center
Conditions:
Psychological
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Fibromyalgia is a chronic pain syndrome, often involves high levels of depression, anxiety and cognitive deficits (e.g., "Fibro Fog"). Mindfulness-based Intervention (MBI), is a mind-body intervention...
Detailed Description
Fibromyalgia Fibromyalgia is a frequently diagnosed pain disorder primarily affecting women and showing high comorbidity with other functional somatic disorders, stress and depression. It is character...
Eligibility Criteria
Inclusion
- confirmation of a clinical diagnosis of Lupus by the patient's own physician
- age 18 years or older
- Hebrew speakers
- physical ability to attend group intervention sessions
- psychological ability to practice mindfulness (no cognitive extreme impairments, no psychosis, no suicidal tendencies)
Exclusion
- serious mental health condition (such as suicidal state, alcohol and drug abuse, schizophrenia)
- serious physical condition that would not enable participation
- participation in another study.
Key Trial Info
Start Date :
January 23 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 8 2018
Estimated Enrollment :
95 Patients enrolled
Trial Details
Trial ID
NCT04304664
Start Date
January 23 2017
End Date
September 8 2018
Last Update
March 11 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Chaim Sheba Medical Center
Ramat Gan, Israel, 52621
2
Bar- Ilan University
Ramat Gan, Israel, 5290002